DAPAgliflozin‐Related Cardiac REverse Remodeling by 2D and 3D Echocardiography in OptiMally Treated HFrEF Patients: The DAPA‐REM Study
Echocardiography · 2026
DOI: 10.1111/echo.70654 ↗At a glance
Beobachtungsstudie in Echocardiography, 2026. Written by Nicola Amelotti and 12 co-authors. Institution: Centro Cardiologico Monzino, IRCCS, Milan, Italy. Major MEDLINE topics: Benzhydryl Compounds, Echocardiography, Echocardiography, Three-Dimensional, Glucosides. 39 references. Funded by: Italian Ministry of Health to Cardiologico Monzino IRCCS.
Abstract (original language)
Purpose
Sodium‐glucose cotransporter‐2 inhibitors promote cardiac reverse remodeling in heart failure (HF), yet data integrating two‐dimensional and three‐dimensional echocardiography (2DE and 3DE, respectively) in optimally treated HFrEF populations are limited. This study aimed to evaluate heart chambers size and function by 2D/3DE after dapagliflozin initiation, and to explore whether baseline estimated glomerular filtration rate (eGFR) or myocardial fibrosis on cardiac magnetic resonance (CMR) influence reverse remodeling.
Methods
Seventy‐five patients with LVEF ≤40% on guideline‐directed therapy were prospectively enrolled. Echocardiographic and clinical data were collected at baseline and 6‐month follow‐up (6MFU) after introduction of dapagliflozin 10 mg daily. Sub‐analyses were performed according to eGFR (
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Centro Cardiologico Monzino, IRCCS, Milan, Italy.
- Department of Clinical Sciences and Community Health, Cardiovascular Section, University of Milan, Milan, Italy.
- Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
Funding
- Italian Ministry of Health to Cardiologico Monzino IRCCS
Cite
APA
Amelotti, N., Mantegazza, V., Garlaschè, A., Salvioni, E., Mapelli, M., Baggiano, A., Muratori, M., Mattavelli, I., Chiesa, M., Caputo, R., Tamborini, G., Agostoni, P., & Pontone, G. (2026). DAPAgliflozin‐Related Cardiac REverse Remodeling by 2D and 3D Echocardiography in OptiMally Treated HFrEF Patients: The DAPA‐REM Study. Echocardiography. https://doi.org/10.1111/echo.70654
Vancouver
Amelotti N, Mantegazza V, Garlaschè A, Salvioni E, Mapelli M, Baggiano A, et al. DAPAgliflozin‐Related Cardiac REverse Remodeling by 2D and 3D Echocardiography in OptiMally Treated HFrEF Patients: The DAPA‐REM Study. Echocardiography. 2026. doi:10.1111/echo.70654
BibTeX
@article{Amelotti2026,
author = {Amelotti, Nicola and Mantegazza, Valentina and Garlaschè, Anna and Salvioni, Elisabetta and Mapelli, Massimo and Baggiano, Andrea and Muratori, Manuela and Mattavelli, Irene and Chiesa, Mattia and Caputo, Rebecca and Tamborini, Gloria and Agostoni, Piergiuseppe and Pontone, Gianluca},
title = {DAPAgliflozin‐Related Cardiac REverse Remodeling by 2D and 3D Echocardiography in OptiMally Treated HFrEF Patients: The DAPA‐REM Study},
journal = {Echocardiography},
year = {2026},
doi = {10.1111/echo.70654}
}
EUVIMED